SCHEMBL1390288

SCHEMBL1390288

Cc1ccccc1C(CC(=O)c1ccc(=O)n(C)c1)c1ccc(C(=O)NCC(O)CO)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.38
GPBAR1 Q8TDU6 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
SLC6A9 P48067 1/20 0.37
EGFR P00533 1/20 0.36
SRC P12931 1/20 0.36
ACSS2 Q9NR19 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAPK14 Q16539 2/20 0.35
PRMT5 O14744 1/20 0.35
EPHX2 P34913 1/20 0.35
GABRA5 P31644 1/20 0.35
BACE1 P56817 1/20 0.34
CREBBP Q92793 1/20 0.34
MEN1 O00255 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1390287 1.00 BRD4 (0.38) BRD4GPBAR1KDM4EALDH1A1HPGD
SCHEMBL1390197 0.89 GPBAR1 (0.47) BRD4GPBAR1KDM4EALDH1A1HPGD
SCHEMBL1390194 0.89 GPBAR1 (0.47) BRD4GPBAR1KDM4EALDH1A1HPGD
SCHEMBL1390191 0.89 GPBAR1 (0.47) BRD4GPBAR1KDM4EALDH1A1HPGD
SCHEMBL1390193 0.89 GPBAR1 (0.47) BRD4GPBAR1KDM4EALDH1A1HPGD
SCHEMBL1390430 0.88 EPHX2 (0.40) BRD4GPBAR1KDM4EALDH1A1SLC6A9
SCHEMBL1390515 0.88 MAPK14 (0.35) BRD4KDM4EALDH1A1HPGDACSS2
SCHEMBL369230 0.88 MAPK14 (0.35) BRD4KDM4EALDH1A1HPGDACSS2
SCHEMBL368576 0.87 SLC6A9 (0.38) BRD4GPBAR1SLC6A9NPC1RAB9A
SCHEMBL1390429 0.87 SLC6A9 (0.43) BRD4GPBAR1KDM4ESLC6A9EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 BRD4 3540/4885GPBAR1 1/4885KDM4E 4298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.